Microelectronic Medical Implants Market Overview 2024-2033 – Competitive Landscape and Strategies

Spread the love

The Microelectronic Medical Implants by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Microelectronic Medical Implants Market:

https://www.thebusinessresearchcompany.com/report/microelectronic-medical-implants-global-market-report

According to The Business Research Company’s Microelectronic Medical Implants, The microelectronic medical implants market size has grown rapidly in recent years. It will grow from $41.26 billion in 2023 to $45.52 billion in 2024 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to cost efficiency and accessibility, rise in chronic diseases, miniaturization of devices, regulatory support and standards, growing acceptance and awareness..

The microelectronic medical implants market size is expected to see rapid growth in the next few years. It will grow to $66.65 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to rise in lifestyle diseases, regulatory support and standards, patient preference for implantable solutions, cost efficiency and accessibility, aging population and chronic diseases.. Major trends in the forecast period include miniaturization and compact designs, wireless connectivity and remote monitoring, advancements in sensor technology, focus on longevity and reliability, biocompatible materials..

The rising prevalence of hearing impairments is expected to boost the microelectronic medical implants market going forward. Hearing impairment is the inability to hear as well as someone with normal hearing, defined as hearing thresholds of 20 dB or better in both ears. Microelectronic medical implants can improve hearing in people with severe hearing loss who are no longer helped by using hearing aids, hence, they will boost the microelectronic medical implants market. For instance, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization responsible for providing leadership on global health matters, in 2021, it is expected that by 2050, approximately 2.5 billion individuals will have some degree of hearing loss, and at least 700 millions of them will need hearing rehabilitation. Therefore, the rising prevalence of hearing impairments is driving the growth of the microelectronic medical implant market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=8992&type=smp

The microelectronic medical implants market covered in this report is segmented –

1) By Product: Neurostimulators, Drug Infusion Pumps, Pacemakers, Defibrillators, Spinal Fusion Stimulators, Implantable Drug Pumps, Hearing Implants, Eye Implants, Ocular Implants, Other Products

2) By Technology: Radiofrequency, Sensors, Other Technologies

3) By Material: Metals, Titanium, Stainless Steel, Platinum, Gold Brazed Alloys, Polymers, Ceramics, Other Materials

4) By Application: Cardiology, Neurology, Ophthalmology, Oncology, Other Applications

5) By End-Users: Hospitals And Clinics, Ambulatory Surgical Centres

Technological advancements have emerged as the key trend gaining popularity in the microelectronic medical implant market. Major companies operating in the microelectronic medical implants market are developing advanced technologies to strengthen their position in the market. For instance, in November 2022, Cochlear Limited, an Australia-based medical device and microelectronic medical implant company, announced that the Cochlear Nucleus 8 Sound Processor had received approval from the U.S. Food and Drug Administration (FDA). The Nucleus 8 Sound Processor incorporates Cochlear’s most recent and advanced hearing technology, which can detect changes in a person’s surroundings and automatically modify their listening settings. It also contains an improved ForwardFocus+ function, which effectively lowers distracting background noise to improve the clarity of face-to-face interactions, even in busy surroundings.

The microelectronic medical implants market report table of contents includes: